Will genome detection replace serology in blood screening for microbial agents?
- 1 December 2000
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Haematology
- Vol. 13 (4) , 615-629
- https://doi.org/10.1053/beha.2000.0103
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Redefining the HIV‐infectious window period in the chimpanzee model: evidence to suggest that viral nucleic acid testing can prevent blood‐borne transmissionTransfusion, 1999
- Incidence of seroconversion to positivity for hepatitis C antibody in repeat blood donors in England, 1993-5BMJ, 1998
- The status of hepatitis C virus screeningTransfusion Medicine Reviews, 1998
- The Risk of Transfusion-Transmitted Viral InfectionsNew England Journal of Medicine, 1996
- Transfusion transmission of human T‐lymphotropic virus types I and II: serologic and polymerase chain reaction results in recipients identified through look‐back investigationsTransfusion, 1993
- Transient High Levels of Viremia in Patients with Primary Human Immunodeficiency Virus Type 1 InfectionNew England Journal of Medicine, 1991
- High Titers of Cytopathic Virus in Plasma of Patients with Symptomatic Primary HIV-1 InfectionNew England Journal of Medicine, 1991
- Rapid Development of Myelopathy after HTLV-I Infection Acquired by Transfusion during Cardiac TransplantationNew England Journal of Medicine, 1990
- SEROLOGICAL MARKERS IN EARLY STAGES OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION IN HAEMOPHILIACSThe Lancet, 1986
- Antibody to Hepatitis B Core Antigen as a Paradoxical Marker for Non-A, Non-B Hepatitis Agents in Donated BloodAnnals of Internal Medicine, 1986